Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Women with polysyctic ovarian syndrome (PCOS) usually develop many complications including asthma. Nowdays, diet restriction combimed with phsyical exercises may improve both problems
Forty Women with asthma with PCOS will be enrolled to be catogrized to Group I or group II. Group I will enroll twenty females with PCOS and asthma who will apply forty minutes walking on treadmill three times per week. Also Group I will follow low calorie diet and daily metformin for 12 weeks. Group II will will enroll twenty females with PCOS and asthma who will follow low calorie diet and daily metformin for 12 weeks
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| group number 1 | Experimental | Group I will enroll twenty females with PCOS and asthma who will apply forty minutes walking on treadmill three times per week. Also Group I will follow low calorie diet and daily metformin for 12 weeks. |
|
| group number 2 | Active Comparator | Group II will will enroll twenty females with PCOS and asthma who will follow low calorie diet and daily metformin for 12 weeks |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| exercise plus limiitng diet | Behavioral | Group I will enroll twenty females with PCOS and asthma who will apply forty minutes walking on treadmill three times per week. Also Group I will follow low calorie diet and daily metformin for 12 weeks. |
| Measure | Description | Time Frame |
|---|---|---|
| forced vital capcity | it is a pulmonary function testing | it will be measured after 12 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| forced expiratory volume | it is a pulmonary function testing at the first second of expiration | It will be measured after 12 weeks |
| forced expiratory volume to forced expiratory capcity | it is a common ratio test in pulmonary function examiantions |
Not provided
Inclusion Criteria:
Exclusion Criteria:
based on self-representation of gender identity.
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Ali MA Ismail, lecturer | Contact | 01005154209 | ali.mohamed@pt.cu.edu.eg | |
| ali mohamed | Contact | 0201031321109 | fatmaraed1994@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Ali MA Ismail, lecturer | Cairo University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Cairo University | Recruiting | Giza | Dokki | Egypt |
Not provided
| ID | Term |
|---|---|
| D011085 | Polycystic Ovary Syndrome |
| D001249 | Asthma |
| ID | Term |
|---|---|
| D010048 | Ovarian Cysts |
| D003560 | Cysts |
| D009369 | Neoplasms |
| D010049 | Ovarian Diseases |
| D000291 |
Not provided
Not provided
| ID | Term |
|---|---|
| D015444 | Exercise |
| ID | Term |
|---|---|
| D009043 | Motor Activity |
| D009068 | Movement |
| D009142 | Musculoskeletal Physiological Phenomena |
| D055687 | Musculoskeletal and Neural Physiological Phenomena |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| limiting diet | Behavioral | Group II will will enroll twenty females with PCOS and asthma who will follow low calorie diet and daily metformin for 12 weeks |
|
| It will be measured after 12 weeks |
| body mass index | it will be assessed on empty stomach and bladder | It will be measured after 12 weeks |
| waist circumference | it will be assessed at level of patient umblicus | it will be measured after 12 weeks |
| waist hip ratio | it is a measure of excess weight | It will be measured after 12 weeks |
| Mini asthma quality of life questionnaire | it is a questioanire assessing life quality in asthma | It will be measured after 12 weeks |
| scale of fatigue severity | it is a questionaire assesing fatigue | It will be measured after 12 weeks |
| luteinizing-hormone to follicle-stimulating-hormone ratio | it is an indicator on level of sex hormone production | It will be measured after 12 weeks |
| Testosterone | it is androgen hormone | It will be measured after 12 weeks |
| Dehydroepiandrosterone | it is a hormone that body naturally produces in the adrenal gland | It will be measured after 12 weeks |
| Adnexal Diseases |
| D005831 | Genital Diseases, Female |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D000091662 | Genital Diseases |
| D006058 | Gonadal Disorders |
| D004700 | Endocrine System Diseases |
| D001982 | Bronchial Diseases |
| D012140 | Respiratory Tract Diseases |
| D008173 | Lung Diseases, Obstructive |
| D008171 | Lung Diseases |
| D012130 | Respiratory Hypersensitivity |
| D006969 | Hypersensitivity, Immediate |
| D006967 | Hypersensitivity |
| D007154 | Immune System Diseases |